Tuesday, May 5, 2015
- 5:30pm-6:30pm
-
The Use of a Nurse Practitioner Led Transitional Diabetes Clinic Following Transplantation
Poster Session D: Disparities in Healthcare Outcomes • Exhibit Hall E
- 5:30pm-6:30pm
-
The use of Donation After Cardiac Death Liver Allografts does not increase Recurrence of Hepatocellular Carcinoma
Poster Session D: Liver Transplantation for Hepatocellular Carcinoma • Exhibit Hall E
- 5:30pm-6:30pm
-
The Value of Surveillance Testing for De Novo Donor Specific Antibodies Following Renal Transplantation
- 5:30pm-6:30pm
-
Transient Lymphopenia Breaks Costimulatory Blockade-Based Transplant Tolerance and Initiates Allograft Rejection
Poster Session D: Costimulation and Signaling in Lymphocytes • Exhibit Hall E
- 5:30pm-6:30pm
-
Treatment With Everolimus and Reduced-Exposure Cyclosporine Is Efficacious in De Novo Renal Transplant Recipients at Increased Risk for Efficacy Failure: Post-Hoc Analysis from the A2309 Study
Poster Session D: Kidney Immunosuppression: Drug Minimization • Exhibit Hall E
- 5:30pm-6:30pm
-
Type III Phosphodiesterase (PDE3) Inhibitor Improves Survival Rate After Ischemia Reperfusion Injury of the Liver in Rats
Poster Session D: Innate Immunity in Transplantation • Exhibit Hall E
- 5:30pm-6:30pm
-
U.S. Population Characteristics Impacting Rates of Organ Donation
Poster Session D: Disparities in Healthcare Outcomes • Exhibit Hall E
- 5:30pm-6:30pm
-
Unrecognized Synchronous Hepatocellcular Carcinoma Lesions in Explanted Liver Transplant Specimens
Poster Session D: Liver Transplantation for Hepatocellular Carcinoma • Exhibit Hall E
- 5:30pm-6:30pm
-
Utilization of Medicare Part D Among Transplant Recipients
Poster Session D: Late Breaking • Exhibit Hall E